LICENSE REVENUES - Schedule of Total Revenue (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Collaborative Arrangements And Noncollaborative Arrangement Transactions Line Items
Total license fee revenue	$ 0	$ 0	$ 1,300,000	$ 100,000
License Fee Revenue
Collaborative Arrangements And Noncollaborative Arrangement Transactions Line Items
Total license fee revenue			1,300,000	100,000
Scithera, Inc. | License Fee Revenue
Collaborative Arrangements And Noncollaborative Arrangement Transactions Line Items
Total license fee revenue			1,300,000	0
Regeneron Pharmaceuticals, Inc. | License Fee Revenue
Collaborative Arrangements And Noncollaborative Arrangement Transactions Line Items
Total license fee revenue			$ 0	$ 100,000